Q4 Earnings Roundup Ashok Leyland JSW Holdings Post Profit Growth Graphite India Reports Loss
Japan Identified as Part of Fentanyl Smuggling Route by US Official Raising Economic and Security Concerns
Bernstein Bullish on Indian Pharma Sees Up to 40 Upside in Six Stocks
Sebi Chief Tuhin Kanta Pandey Advocates for Bond ETFs and Tokenisation as Corporate Debt Fundraising Approaches Rs 9 Lakh Crore
OpenAIs Potential IPO Could Be Largest in History Challenging SpaceXs Lead
Guzman y Gomez Exits US Market Amid Stiff Competition and Operational Challenges
HBT Q1 2026 Earnings EPS Misses Estimates by 4481 as Net Income Falls Short
BGSI Q1 2026 Earnings Earnings Slightly Miss Estimates as Stock Edges Lower
Cousins Properties CUZ Q1 2026 Earnings EPS Beats Expectations Amid Stable Office Market
CVBF Q1 2026 Earnings EPS Misses Estimates Amid Challenging Interest Rate Environment
InflaRx NV IFRX Q4 2025 Earnings Narrower Loss and Pipeline Progress Lift Sentiment
MeiraGTx Holdings plc MGTX Q1 2026 Earnings WiderthanExpected Loss Amid Clinical Progress
GTEC Holds Near Support After Marginal Gains Greenland Technologies in Focus
Resolute Holdings Management RHLD Holds Steady Near 1145 Amid Consolidation
AEFC Holds Steady Aegon Funding Subordinated Notes Remain Stable at 1917
UniFuels Holdings UFG Slips 318 as Stock Tests Key Support Near 067
NovaBay Pharmaceuticals NBY Jumps 226 as Trading Volume Surges
LICs Valuation Cheap PE Masks Potential Expense Based on VNB Metrics
FLD Q1 2026 Earnings Significant EPS Miss Sends Stock Lower
Iveda Solutions Warrant IVDAW Holds Steady at 003 Amid Minimal Volatility
Nyxoah NYXH Q1 2026 Earnings NarrowerThanExpected Loss as PreRevenue Biotech Advances Sleep Apnea Pipeline
Schneider National Q1 2026 Earnings EPS Surpasses Expectations on Strong Cost Control
IsoEnergy Q1 2026 Earnings Narrower Than Expected Loss as Uranium Developer Advances Projects
Diversified Healthcare Trust 5625 Senior Notes due 2042 DHCNI Q1 2026 Earnings Deeper EPS Miss Signals Persistent Headwinds
Skye Bioscience Q1 2026 Earnings Wider Loss Than Expected as DevelopmentStage Biotech Continues Cash Burn
BJ Q1 2026 Earnings EPS Beat Fails to Lift Stock
AEMD Q1 2026 Earnings NarrowerthanExpected Loss Boosts Investor Sentiment